Software & SaaS

A new platform, Venn.ai, promises to let AI take real action in business apps, but with a critical feature: a human-in-the-loop safety switch.

After an 8-year hiatus, Elizabeth Arden launches Eternal Aura. A look at the strategy combining a new star, wellness science, and heritage to reclaim its spot.

Riding a wave of 41% Q4 revenue growth and nearing profitability, the diagnostics firm will showcase its lung cancer solutions at two major conferences.

A new partnership brings premium anime to Times Prime members, a strategic move to capture India's booming, multi-billion dollar anime market.

With $1.2M in new funding, Validfor is unleashing agentic AI to tackle pharma's billion-dollar compliance problem and slash validation times.

Nokia and AWS launch a thinking 5G network with du and Orange. Their agentic AI promises to unlock the true business potential of network slicing.

A new screen protector promises glasses-free 3D on your iPhone. Can MOPIC succeed where tech giants have repeatedly failed?

Drilling at the Tesorito deposit has intersected a potential high-grade feeder zone, suggesting a much larger and richer system than previously modeled.

A new 'technology-only' law firm has been approved in the UK. Can its deterministic AI make legal help more affordable and consistent for everyone?

After a challenging year, iGaming affiliate Gentoo Media posts record Q4 profits, signaling a successful pivot to a leaner model ahead of a key refinancing.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

An innovative insurance program for BYD vehicles is removing key barriers for EV adoption, accelerating Indonesia's shift to sustainable transport.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

Creatd Inc. executes a 1:20 reverse stock split to chase a national exchange listing. Is it a strategic masterstroke or a sign of deeper struggles?

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

A former hedge fund manager's stark video presentation warns that AI will permanently alter work and wealth. Are American workers prepared for what's next?

Following strong earnings and a major SAP settlement, Teradata will detail its AI-driven future and financial outlook at two key investor conferences.